AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Septablue M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Medcure Pharma

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Septablue M 50mg/500mg Tablet

Diabex Duo 50mg/500mg tablets combine two medications to effectively manage elevated blood glucose in patients with type 2 diabetes. This dual action helps prevent serious diabetic complications like vision impairment and kidney disease, and may lessen the risk of stroke or heart attack. Diabex Duo 50mg/500mg may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering current health status, blood sugar readings, and concurrent medications. Consuming the tablets with food minimizes stomach upset. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes control, as lifestyle factors significantly influence management. Common side effects include nausea, diarrhea, vomiting, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when used with insulin or sulfonylureas; patients should be educated on its recognition and treatment. This medication isn't suitable for all individuals. Prior to commencement, inform your physician of any history of liver, kidney, or heart disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical counsel before use. Interaction with other medications is possible; a complete medication list should be provided to your doctor for safety assessment. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood sugar levels throughout treatment.

Primary Ingredients of Septablue M 50mg/500mg Tablet

No text provided. Please provide the text you wish me to rephrase.

Uses of Septablue M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Septablue M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Septablue M 50mg/500mg Tablet with a meal.

Common Side effects of Septablue M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Septablue M 50mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 50mg/500mg Septablue M tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

How Septablue M 50mg/500mg Tablet works:

Sitagliptin/metformin (Septablue M 50mg/500mg) tablets combine two glucose-regulating agents. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. This dual action promotes superior blood glucose management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Septablue M 50mg/500mg tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Septablue M 50mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. It is essential to seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Septablue M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

For individuals with kidney impairment, Septablue M 50mg/500mg tablets require careful administration and may necessitate dosage modification. Patients with severe kidney disease should avoid this medication. Close monitoring of kidney function is recommended during treatment. Physician consultation is advised.

LiverLiverUNSAFE

The use of Septablue M 50mg/500mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided unless specifically directed by a physician. Medical consultation is recommended.

What if you forget to take Septablue M 50mg/500mg Tablet :

Should you forget a Septablue M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Septablue M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Type of Therapy Diabetes Management

FAQs on Septablue M 50mg/500mg Tablet

Septablue M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is unsuitable for individuals under 18.
Prolonged use of Septablue M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Septablue M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Septablue M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Septablue M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Septablue M 50mg/500mg Tablets can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Septablue M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication helps control blood sugar when used with diet and exercise. Metformin reduces liver glucose production and improves insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Septablue M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Septablue M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Septablue M 50mg/500mg tablets with alcohol is unsafe and may heighten the risk of lactic acidosis.
Septablue M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or those consuming large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Septablue M 50mg/500mg tablets can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left unaddressed, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Septablue M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Septablue M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Septablue M 50mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient. This medication should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Septablue M 50mg/500mg tablets with alcohol is unsafe and may raise the risk of lactic acidosis.
Septablue M 50mg/500mg Tablets can cause lactic acidosis (MALA, or Metformin-associated lactic acidosis), a serious medical emergency involving high blood lactic acid levels. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of Septablue M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Septablue M 50mg/500mg Ta...
237
MRP 275
13% off